Physician profile
Ravnit Singh
NPI 1437778495
$2,705.30
in general payments reported to CMS, 2019-2025
7 companies · $2,613 in 2025
The $2,613 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $92.31 · 2025: $2,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,463 · Food and Beverage: $1,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,463.29 |
| Food and Beverage | $1,242.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,274.16 | 2025 | |
| Abiomed | $201.79 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $109.91 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.64 | 2024 | Lifevest |
| Pfizer INC. | $30.00 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $24.93 | 2024 | Uptravi, Opsumit |
| Cvrx, INC. | $21.87 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravnit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.